vaccines
Dr. Samuel Katz: The Man Who Helped Conquer Measles
Dr. Samuel Katz made monumental contributions to pediatric health and vaccinations before his passing on October 31, 2022, at the age of 95. His career was proof that one dedicated individual can have a profound impact on global public health.
Born on May 29, 1927, in Manchester, NH, Samuel Katz initially studied journalism at Dartmouth College, but quickly switched to medicine after a stint in the Navy during World War II. Moving on to his medical studies at Harvard Medical School, he was drawn into the world of virology under the tutelage of John Enders, a Nobel Laureate. This collaboration marked the beginning of Katz’s lifelong battle against infectious diseases, which included the development of the measles vaccine.
Europe and the U.S. Battle Measles – Again
Initially, doctors in the Tuzla Canton of the Federation of Bosnia and Herzegovina thought the rash on young Imran’s* stomach could be scarlet fever. Or maybe it was Kawasaki disease. As reported by Eurosurveillance, that was in early December 2023. By Christmas, four of Imran’s preschool classmates had been admitted to the hospital with measles. By mid-January 2024, another epidemiologically linked case – again originally misdiagnosed as the much less contagious scarlet fever – presented in a neighboring canton. Two more quickly followed. Between the last week of December and the middle of February, the Balkan nation had reported 141 new measles cases.
Barts Health Trust’s Dr. David Harrington said the misdiagnoses should not be unexpected.
“Many front-line clinicians won’t have seen measles for several years,” he told Medscape UK. “So good education and training and collaboration between public health and infection specialists with those in primary and emergency care is key.”
Dr. Peter Hotez: Fighting Neglected Diseases, One Shot at a Time
Dr. Peter J. Hotez is a physician-scientist who dedicates his career to fighting neglected tropical diseases and vaccine development. He is the Dean of the National School of Tropical Medicine and a professor at Baylor College of Medicine, where he also serves as the Co-director of the Texas Children’s Center for Vaccine Development (CVD) and the Texas Children’s Hospital Endowed Chair of Tropical Pediatrics.
Dr. Hotez is an internationally recognized expert in his field, leading a team and product development partnership for new vaccines for diseases such as hookworm infection, schistosomiasis, leishmaniasis, Chagas disease, and coronaviruses, which affect millions of people worldwide. He is committed to championing global access to vaccines, including leading efforts to develop a low-cost recombinant protein COVID vaccine resulting in emergency use authorization in India.